alexa New Technology Of Nucleoside AIDS Virus Resistance Drug Key Intermediate Diethyl (tosyloxy) Methylphosphonate
ISSN 2472-1042

Pharmacoeconomics: Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
February 27-28, 2017 Amsterdam, Netherlands

Rahul Hajare and Ramesh Paranjape
Rajgad Dnyanpeeth's College of Pharmacy, India
National AIDS Research Institute, India
Posters & Accepted Abstracts: Pharmacoeconomics
DOI: 10.4172/2472-1042.C1.003
Abstract
A bioprocess is composed mainly of three stages i.e., upstream processing, bio-reaction and downstream processing to convert raw material to pure finished product. Cost- effective auto bioreactor laboratory device of nucleoside AIDS virus resistance drug key intermediate diethyl (tosyloxy) methylphosphonate, which a chemical process is carried out by agitator to form perfect homogeneous condition for better transport of diethyl phosphite part and paraformaldehyde in required quantity as raw material is placed in water to react for 1-2 hours under the temperature ranging from 50-55ºC, the reaction is completed in separate matrix vessel and room temperature is maintained to prepare the diethyl (hydroxymethyl) phosphate. Then transport diethyl (hydroxymethyl) phosphate as a raw material was added to paratoluensulfonyl chloride, taking an acid binding agent as a catalyst (ammonia) to react for 4-5 hours under the temperature ranging from 50-55ºC in a mixing vessel with supportive baffle to avoid undesirable changes to the center of gravity of the system and to reduce the consumption of additional power. The new technology has short reaction time, high production yield coefficient, little environment pollution and the obtained product has high purity. No bubbling and foaming was observed due to separate matrix and mixing vessel, and low shear stress reducing debris. The new bioreactor technology can also reduce the CO2 emission.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords